Respiratorius AB (XSAT:RESP) Shares Buyback Ratio %: -54.99 (As of Sep. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:RESP Respiratorius AB XSAT:RESP
32 GF Score
Price kr2.29
View Full Analysis

What is Respiratorius AB Shares Buyback Ratio %?

Respiratorius AB XSAT:RESP +5.53% 32 Shares Buyback Ratio % is -54.99 as of Sep. 13, 2026. GuruFocus rates XSAT:RESP with a GF Score™ of 32/100.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Respiratorius AB's current shares buyback ratio was -54.99%.

Respiratorius AB Shares Buyback Ratio % Related Terms

Respiratorius AB Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Shares Buyback Ratio % Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.39 -25.94 0.00 -74.44 -54.99

Respiratorius AB Quarterly Data
Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -54.99 0.00 0.00 0.00
XSAT:RESP
32GF Score
Respiratorius AB XSAT:RESP
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB Shares Buyback Ratio % Calculation

Respiratorius AB's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(5.099 - 7.903) / 5.099
=-54.99%

Respiratorius AB's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(7.903 - 7.903) / 7.903
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -54.99 mean?
Respiratorius AB (XSAT:RESP) has a Shares Buyback Ratio % of -54.99 as of Sep. 13, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Respiratorius AB and its competitors.
Is Respiratorius AB's Shares Buyback Ratio % too high?
Respiratorius AB's current Shares Buyback Ratio % is -54.99. Overall, Respiratorius AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's Shares Buyback Ratio % compare to VRTX and REGN?
Respiratorius AB's Shares Buyback Ratio % of -54.99 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Respiratorius AB and its competitors. Respiratorius AB's current Shares Buyback Ratio % is -54.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (XSAT:RESP) has a current Shares Buyback Ratio % of -54.99. The current Shares Buyback Ratio % is -54.99. Respiratorius AB's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Respiratorius AB (XSAT:RESP), the current Shares Buyback Ratio % is -54.99 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
32GF Score

Get the complete analysis for XSAT:RESP

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.29
Price